As of 2024-12-12, the Relative Valuation of Landos Biopharma Inc (LABP) is (173.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -857.5%.
The range of the Relative Valuation is (175.87) - (202.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 25.6x | 18.8x |
| Forward P/E multiples | 22.2x - 26.2x | 25.0x |
| Fair Price | (175.87) - (202.80) | (173.69) |
| Upside | -867.0% - -984.4% | -857.5% |
| Date | P/E |